Apolipoprotein B and apolipopotein A-I in vascular risk prediction - a review

Area of Science:

• Cardiovascular Medicine
• Lipid Metabolism
• Epidemiology

Background:

• Low-density lipoprotein cholesterol is a recognized cardiovascular disease risk factor.
• Emerging evidence suggests apolipoprotein ratios may offer superior risk prediction.
• Focus on epidemiological data, excluding pharmaceutical intervention studies.

Purpose of the Study:

• To review epidemiological studies on apolipoprotein B (apoB) and apolipoprotein A-I (apoA-I) for vascular risk prediction.
• To compare the predictive power of apoB/apoA-I ratio against conventional lipid markers.

Main Methods:

• Systematic review of epidemiological research.
• Analysis of studies investigating apoB, apoA-I, and their ratio in relation to vascular events.
• Exclusion of studies focused on pharmaceutical interventions.

Main Results:

• The majority of reviewed studies indicate apoB and the apoB/apoA-I ratio are stronger independent predictors of vascular risk.
• This enhanced predictive capability is observed across different age groups and geographic regions.
• ApoB and apoB/apoA-I demonstrate greater association with vascular risk than conventional lipids and lipoproteins.

Conclusions:

• Apolipoprotein B and the apoB/apoA-I ratio are highly effective markers for predicting vascular risk in epidemiological contexts.
• These apolipoprotein markers surpass traditional lipid profiles in identifying individuals at risk for cardiovascular disease.
• Further emphasis on apoB/apoA-I ratio in risk assessment strategies is warranted based on epidemiological evidence.